Stocklytics Platform
Asset logo for symbol PYXS
Pyxis Oncology
PYXS52
$3.40arrow_drop_down3.95%-$0.14
Penny Stock
Asset logo for symbol PYXS
PYXS52

$3.40

arrow_drop_down3.95%

Performance History

Chart placeholder
Key Stats
Open$3.50
Prev. Close$3.51
EPS-1.27
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$208.57M
PE Ratio-
LOWHIGH
Day Range3.46
3.65
52 Week Range1.35
6.85
Ratios
Revenue-
EBITDA Margin %-
EPS-1.27

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Pyxis Oncology (PYXS)

Pyxis Oncology, Inc. (PYXS) is a biotechnology company specializing in the development of innovative cancer therapeutics. With a focus on harnessing the power of the immune system to fight cancer, Pyxis Oncology aims to revolutionize the treatment landscape and improve patient outcomes. The company's cutting-edge research and development efforts have garnered attention from investors and industry experts alike, positioning Pyxis Oncology as a promising player in the oncology space.
One of the key indicators of Pyxis Oncology's success is its stock price history. Over the past several years, PYXS stock has experienced significant growth, reflecting the market's confidence in the company's potential. Investors have been drawn to Pyxis Oncology's innovative approach to cancer treatment, recognizing the value of its groundbreaking research and development pipeline. As a result, PYXS stock has consistently outperformed industry averages, making it an attractive investment opportunity for those looking to capitalize on the rapidly evolving field of oncology.
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Lara S. Sullivan M.D., MBA
Headquarters
Cambridge
Employees
72
Exchange
NASDAQ
add Pyxis Oncology to watchlist

Keep an eye on Pyxis Oncology

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Pyxis Oncology's (PYXS) price per share?

The current price per share for Pyxis Oncology (PYXS) is $3.4. The stock has seen a price change of -$0.14 recently, indicating a -3.95% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Pyxis Oncology (PYXS)?

For Pyxis Oncology (PYXS), the 52-week high is $6.85, which is 101.47% from the current price. The 52-week low is $1.35, the current price is 151.85% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Pyxis Oncology (PYXS) a growth stock?

Pyxis Oncology (PYXS) has shown an average price growth of 0.41% over the past three years. It has received a score of 85 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Pyxis Oncology as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Pyxis Oncology (PYXS) stock price performance year to date (YTD)?

As of the latest data, Pyxis Oncology (PYXS) has a year-to-date price change of 65.05%. Over the past month, the stock has experienced a price change of -1.16%. Over the last three months, the change has been 18.06%. Over the past six months, the figure is -38.96%.
help

Is Pyxis Oncology (PYXS) a profitable company?

Pyxis Oncology (PYXS) has a net income of -$73.79M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -409.25% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$80.42M. Furthermore, the EBITDA is -$63.16M.
help

What is the market capitalization of Pyxis Oncology (PYXS)?

Pyxis Oncology (PYXS) has a market capitalization of $208.57M. The average daily trading volume is 3.42, indicating the stock's liquidity and investor engagement.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media